nodes	percent_of_prediction	percent_of_DWPC	metapath
Sumatriptan—DRD2—nicotine dependence	0.704	1	CbGaD
Sumatriptan—Meniere's disease—Varenicline—nicotine dependence	0.0198	0.0963	CcSEcCtD
Sumatriptan—Dissociation—Varenicline—nicotine dependence	0.0113	0.0553	CcSEcCtD
Sumatriptan—Rhinitis allergic—Varenicline—nicotine dependence	0.00725	0.0353	CcSEcCtD
Sumatriptan—HTR3A—Ligand-gated ion channel transport—GABRA4—nicotine dependence	0.00567	0.083	CbGpPWpGaD
Sumatriptan—Polydipsia—Varenicline—nicotine dependence	0.00531	0.0259	CcSEcCtD
Sumatriptan—Sensory disturbance—Varenicline—nicotine dependence	0.00531	0.0259	CcSEcCtD
Sumatriptan—Facial paralysis—Varenicline—nicotine dependence	0.00518	0.0252	CcSEcCtD
Sumatriptan—VIIth nerve paralysis—Varenicline—nicotine dependence	0.00401	0.0196	CcSEcCtD
Sumatriptan—DRD2—Nicotine Activity on Dopaminergic Neurons—CHRNA6—nicotine dependence	0.00333	0.0487	CbGpPWpGaD
Sumatriptan—Transient ischaemic attack—Varenicline—nicotine dependence	0.00326	0.0159	CcSEcCtD
Sumatriptan—Suicide—Varenicline—nicotine dependence	0.00317	0.0155	CcSEcCtD
Sumatriptan—Sleep disturbance—Varenicline—nicotine dependence	0.00294	0.0143	CcSEcCtD
Sumatriptan—Completed suicide—Varenicline—nicotine dependence	0.0028	0.0136	CcSEcCtD
Sumatriptan—Toothache—Varenicline—nicotine dependence	0.00271	0.0132	CcSEcCtD
Sumatriptan—Cyst—Varenicline—nicotine dependence	0.00246	0.012	CcSEcCtD
Sumatriptan—Intestinal obstruction—Varenicline—nicotine dependence	0.00242	0.0118	CcSEcCtD
Sumatriptan—Menstrual disorder—Varenicline—nicotine dependence	0.00242	0.0118	CcSEcCtD
Sumatriptan—Haematemesis—Varenicline—nicotine dependence	0.00237	0.0115	CcSEcCtD
Sumatriptan—Thrombosis—Varenicline—nicotine dependence	0.00233	0.0113	CcSEcCtD
Sumatriptan—Nystagmus—Varenicline—nicotine dependence	0.00231	0.0112	CcSEcCtD
Sumatriptan—Extrapyramidal disorder—Varenicline—nicotine dependence	0.00219	0.0107	CcSEcCtD
Sumatriptan—Scotoma—Varenicline—nicotine dependence	0.00217	0.0106	CcSEcCtD
Sumatriptan—DRD2—Nicotine Activity on Dopaminergic Neurons—CHRNA5—nicotine dependence	0.00215	0.0314	CbGpPWpGaD
Sumatriptan—Mydriasis—Varenicline—nicotine dependence	0.00206	0.0101	CcSEcCtD
Sumatriptan—Nephrolithiasis—Varenicline—nicotine dependence	0.00205	0.00998	CcSEcCtD
Sumatriptan—HTR1F—brain—nicotine dependence	0.00203	0.0893	CbGeAlD
Sumatriptan—Dysphonia—Varenicline—nicotine dependence	0.002	0.00975	CcSEcCtD
Sumatriptan—Eye irritation—Varenicline—nicotine dependence	0.00193	0.0094	CcSEcCtD
Sumatriptan—HTR1F—Monoamine GPCRs—DRD2—nicotine dependence	0.00189	0.0277	CbGpPWpGaD
Sumatriptan—Tenderness—Varenicline—nicotine dependence	0.00189	0.0092	CcSEcCtD
Sumatriptan—Aggression—Varenicline—nicotine dependence	0.00187	0.00913	CcSEcCtD
Sumatriptan—Chest discomfort—Varenicline—nicotine dependence	0.00186	0.00907	CcSEcCtD
Sumatriptan—Ventricular extrasystoles—Varenicline—nicotine dependence	0.00182	0.00888	CcSEcCtD
Sumatriptan—Gastrooesophageal reflux disease—Varenicline—nicotine dependence	0.00182	0.00888	CcSEcCtD
Sumatriptan—Viral infection—Varenicline—nicotine dependence	0.00182	0.00888	CcSEcCtD
Sumatriptan—Lacrimation increased—Varenicline—nicotine dependence	0.00179	0.00871	CcSEcCtD
Sumatriptan—DRD2—Nicotine Activity on Dopaminergic Neurons—CHRNA3—nicotine dependence	0.00175	0.0256	CbGpPWpGaD
Sumatriptan—Dysarthria—Varenicline—nicotine dependence	0.00174	0.00848	CcSEcCtD
Sumatriptan—HTR1B—cardiovascular system—nicotine dependence	0.0017	0.0746	CbGeAlD
Sumatriptan—Coordination abnormal—Varenicline—nicotine dependence	0.00168	0.00817	CcSEcCtD
Sumatriptan—Musculoskeletal pain—Varenicline—nicotine dependence	0.00167	0.00812	CcSEcCtD
Sumatriptan—Blood pressure increased—Varenicline—nicotine dependence	0.00165	0.00802	CcSEcCtD
Sumatriptan—Pulmonary embolism—Varenicline—nicotine dependence	0.00165	0.00802	CcSEcCtD
Sumatriptan—HTR1D—cardiovascular system—nicotine dependence	0.00164	0.0722	CbGeAlD
Sumatriptan—Eructation—Varenicline—nicotine dependence	0.00162	0.00788	CcSEcCtD
Sumatriptan—Salivary hypersecretion—Varenicline—nicotine dependence	0.0016	0.00779	CcSEcCtD
Sumatriptan—HTR1F—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00159	0.0233	CbGpPWpGaD
Sumatriptan—Photophobia—Varenicline—nicotine dependence	0.00155	0.00753	CcSEcCtD
Sumatriptan—DRD2—Nicotine Activity on Dopaminergic Neurons—CHRNB2—nicotine dependence	0.00154	0.0225	CbGpPWpGaD
Sumatriptan—Euphoric mood—Varenicline—nicotine dependence	0.00141	0.00689	CcSEcCtD
Sumatriptan—Lymphadenopathy—Varenicline—nicotine dependence	0.0014	0.00683	CcSEcCtD
Sumatriptan—DRD2—Nicotine Activity on Dopaminergic Neurons—CHRNA4—nicotine dependence	0.0014	0.0205	CbGpPWpGaD
Sumatriptan—Sleep disorder—Varenicline—nicotine dependence	0.00138	0.00673	CcSEcCtD
Sumatriptan—HTR1A—cardiovascular system—nicotine dependence	0.00137	0.0602	CbGeAlD
Sumatriptan—Deafness—Varenicline—nicotine dependence	0.00134	0.00651	CcSEcCtD
Sumatriptan—Eczema—Varenicline—nicotine dependence	0.00133	0.00648	CcSEcCtD
Sumatriptan—HTR1B—midbrain—nicotine dependence	0.00132	0.0582	CbGeAlD
Sumatriptan—Eye pain—Varenicline—nicotine dependence	0.00132	0.00645	CcSEcCtD
Sumatriptan—Renal failure acute—Varenicline—nicotine dependence	0.00129	0.00631	CcSEcCtD
Sumatriptan—HTR1F—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.00129	0.0189	CbGpPWpGaD
Sumatriptan—HTR1D—midbrain—nicotine dependence	0.00128	0.0564	CbGeAlD
Sumatriptan—Atrial fibrillation—Varenicline—nicotine dependence	0.00126	0.00615	CcSEcCtD
Sumatriptan—Visual disturbance—Varenicline—nicotine dependence	0.00126	0.00615	CcSEcCtD
Sumatriptan—Thirst—Varenicline—nicotine dependence	0.00126	0.00612	CcSEcCtD
Sumatriptan—MAOA—cardiovascular system—nicotine dependence	0.00125	0.055	CbGeAlD
Sumatriptan—SLCO1A2—midbrain—nicotine dependence	0.00125	0.0548	CbGeAlD
Sumatriptan—HTR3A—Ion channel transport—GABRA4—nicotine dependence	0.00123	0.018	CbGpPWpGaD
Sumatriptan—Arthritis—Varenicline—nicotine dependence	0.00123	0.00599	CcSEcCtD
Sumatriptan—Hypoglycaemia—Varenicline—nicotine dependence	0.00122	0.00597	CcSEcCtD
Sumatriptan—Cerebrovascular accident—Varenicline—nicotine dependence	0.00122	0.00594	CcSEcCtD
Sumatriptan—HTR3A—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00122	0.0178	CbGpPWpGaD
Sumatriptan—HTR1D—Monoamine GPCRs—DRD2—nicotine dependence	0.00121	0.0177	CbGpPWpGaD
Sumatriptan—Osteoarthritis—Varenicline—nicotine dependence	0.0012	0.00582	CcSEcCtD
Sumatriptan—Gastrointestinal haemorrhage—Varenicline—nicotine dependence	0.0012	0.00582	CcSEcCtD
Sumatriptan—HTR1B—Monoamine GPCRs—DRD2—nicotine dependence	0.00119	0.0174	CbGpPWpGaD
Sumatriptan—Migraine—Varenicline—nicotine dependence	0.00118	0.00573	CcSEcCtD
Sumatriptan—MAOA—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00113	0.0165	CbGpPWpGaD
Sumatriptan—Liver function test abnormal—Varenicline—nicotine dependence	0.0011	0.00538	CcSEcCtD
Sumatriptan—Cramp muscle—Varenicline—nicotine dependence	0.00108	0.00524	CcSEcCtD
Sumatriptan—HTR1A—midbrain—nicotine dependence	0.00107	0.047	CbGeAlD
Sumatriptan—Gastritis—Varenicline—nicotine dependence	0.00106	0.00515	CcSEcCtD
Sumatriptan—Abdominal distension—Varenicline—nicotine dependence	0.00104	0.00507	CcSEcCtD
Sumatriptan—Dysphagia—Varenicline—nicotine dependence	0.00103	0.00503	CcSEcCtD
Sumatriptan—Asthma—Varenicline—nicotine dependence	0.00103	0.00503	CcSEcCtD
Sumatriptan—HTR1D—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00102	0.0149	CbGpPWpGaD
Sumatriptan—Angina pectoris—Varenicline—nicotine dependence	0.00101	0.0049	CcSEcCtD
Sumatriptan—HTR1B—Amine ligand-binding receptors—DRD2—nicotine dependence	0.000997	0.0146	CbGpPWpGaD
Sumatriptan—Bronchitis—Varenicline—nicotine dependence	0.000994	0.00484	CcSEcCtD
Sumatriptan—HTR3A—brain—nicotine dependence	0.000992	0.0436	CbGeAlD
Sumatriptan—Abdominal discomfort—Varenicline—nicotine dependence	0.00099	0.00483	CcSEcCtD
Sumatriptan—MAOA—midbrain—nicotine dependence	0.000976	0.0429	CbGeAlD
Sumatriptan—DRD2—midbrain—nicotine dependence	0.000966	0.0425	CbGeAlD
Sumatriptan—Pollakiuria—Varenicline—nicotine dependence	0.000954	0.00465	CcSEcCtD
Sumatriptan—Photosensitivity reaction—Varenicline—nicotine dependence	0.000943	0.0046	CcSEcCtD
Sumatriptan—Weight increased—Varenicline—nicotine dependence	0.00094	0.00458	CcSEcCtD
Sumatriptan—Hyperglycaemia—Varenicline—nicotine dependence	0.000932	0.00454	CcSEcCtD
Sumatriptan—Depression—Varenicline—nicotine dependence	0.000918	0.00448	CcSEcCtD
Sumatriptan—Acute coronary syndrome—Varenicline—nicotine dependence	0.000908	0.00442	CcSEcCtD
Sumatriptan—HTR1A—Monoamine GPCRs—DRD2—nicotine dependence	0.000904	0.0132	CbGpPWpGaD
Sumatriptan—Myocardial infarction—Varenicline—nicotine dependence	0.000903	0.0044	CcSEcCtD
Sumatriptan—Conjunctivitis—Varenicline—nicotine dependence	0.000895	0.00436	CcSEcCtD
Sumatriptan—Epistaxis—Varenicline—nicotine dependence	0.000869	0.00423	CcSEcCtD
Sumatriptan—Sinusitis—Varenicline—nicotine dependence	0.000864	0.00421	CcSEcCtD
Sumatriptan—ABCG2—midbrain—nicotine dependence	0.000846	0.0372	CbGeAlD
Sumatriptan—Bradycardia—Varenicline—nicotine dependence	0.000842	0.0041	CcSEcCtD
Sumatriptan—HTR1B—brain—nicotine dependence	0.000832	0.0366	CbGeAlD
Sumatriptan—HTR1D—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.000826	0.0121	CbGpPWpGaD
Sumatriptan—Hallucination—Varenicline—nicotine dependence	0.000823	0.00401	CcSEcCtD
Sumatriptan—Hypoaesthesia—Varenicline—nicotine dependence	0.000823	0.00401	CcSEcCtD
Sumatriptan—Connective tissue disorder—Varenicline—nicotine dependence	0.000813	0.00396	CcSEcCtD
Sumatriptan—HTR3A—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.000811	0.0119	CbGpPWpGaD
Sumatriptan—HTR1B—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.000809	0.0118	CbGpPWpGaD
Sumatriptan—HTR1D—brain—nicotine dependence	0.000806	0.0354	CbGeAlD
Sumatriptan—Visual impairment—Varenicline—nicotine dependence	0.000797	0.00388	CcSEcCtD
Sumatriptan—SLCO1A2—brain—nicotine dependence	0.000783	0.0344	CbGeAlD
Sumatriptan—HTR1F—GPCR ligand binding—TAS2R16—nicotine dependence	0.000782	0.0115	CbGpPWpGaD
Sumatriptan—MAOA—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.000776	0.0114	CbGpPWpGaD
Sumatriptan—Eye disorder—Varenicline—nicotine dependence	0.000773	0.00377	CcSEcCtD
Sumatriptan—Tinnitus—Varenicline—nicotine dependence	0.000771	0.00376	CcSEcCtD
Sumatriptan—HTR1A—Amine ligand-binding receptors—DRD2—nicotine dependence	0.000759	0.0111	CbGpPWpGaD
Sumatriptan—Angiopathy—Varenicline—nicotine dependence	0.00075	0.00366	CcSEcCtD
Sumatriptan—Immune system disorder—Varenicline—nicotine dependence	0.000747	0.00364	CcSEcCtD
Sumatriptan—Mediastinal disorder—Varenicline—nicotine dependence	0.000745	0.00363	CcSEcCtD
Sumatriptan—Chills—Varenicline—nicotine dependence	0.000742	0.00362	CcSEcCtD
Sumatriptan—Arrhythmia—Varenicline—nicotine dependence	0.000739	0.0036	CcSEcCtD
Sumatriptan—HTR3A—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.000736	0.0108	CbGpPWpGaD
Sumatriptan—MAOA—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.000735	0.0108	CbGpPWpGaD
Sumatriptan—Erythema—Varenicline—nicotine dependence	0.00072	0.00351	CcSEcCtD
Sumatriptan—Flatulence—Varenicline—nicotine dependence	0.000709	0.00346	CcSEcCtD
Sumatriptan—Dysgeusia—Varenicline—nicotine dependence	0.000705	0.00343	CcSEcCtD
Sumatriptan—Back pain—Varenicline—nicotine dependence	0.000696	0.00339	CcSEcCtD
Sumatriptan—Muscle spasms—Varenicline—nicotine dependence	0.000692	0.00337	CcSEcCtD
Sumatriptan—Tremor—Varenicline—nicotine dependence	0.000674	0.00329	CcSEcCtD
Sumatriptan—HTR1A—brain—nicotine dependence	0.000672	0.0295	CbGeAlD
Sumatriptan—Ill-defined disorder—Varenicline—nicotine dependence	0.000668	0.00325	CcSEcCtD
Sumatriptan—Anaemia—Varenicline—nicotine dependence	0.000665	0.00324	CcSEcCtD
Sumatriptan—Agitation—Varenicline—nicotine dependence	0.000662	0.00322	CcSEcCtD
Sumatriptan—Angioedema—Varenicline—nicotine dependence	0.000658	0.00321	CcSEcCtD
Sumatriptan—Malaise—Varenicline—nicotine dependence	0.000649	0.00316	CcSEcCtD
Sumatriptan—Vertigo—Varenicline—nicotine dependence	0.000647	0.00315	CcSEcCtD
Sumatriptan—Syncope—Varenicline—nicotine dependence	0.000646	0.00315	CcSEcCtD
Sumatriptan—Palpitations—Varenicline—nicotine dependence	0.000636	0.0031	CcSEcCtD
Sumatriptan—Loss of consciousness—Varenicline—nicotine dependence	0.000633	0.00308	CcSEcCtD
Sumatriptan—Cough—Varenicline—nicotine dependence	0.000628	0.00306	CcSEcCtD
Sumatriptan—Convulsion—Varenicline—nicotine dependence	0.000624	0.00304	CcSEcCtD
Sumatriptan—MAOA—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.000622	0.0091	CbGpPWpGaD
Sumatriptan—Hypertension—Varenicline—nicotine dependence	0.000621	0.00303	CcSEcCtD
Sumatriptan—HTR1A—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.000616	0.00902	CbGpPWpGaD
Sumatriptan—MAOA—brain—nicotine dependence	0.000613	0.027	CbGeAlD
Sumatriptan—Chest pain—Varenicline—nicotine dependence	0.000613	0.00299	CcSEcCtD
Sumatriptan—Arthralgia—Varenicline—nicotine dependence	0.000613	0.00299	CcSEcCtD
Sumatriptan—Myalgia—Varenicline—nicotine dependence	0.000613	0.00299	CcSEcCtD
Sumatriptan—Anxiety—Varenicline—nicotine dependence	0.000611	0.00298	CcSEcCtD
Sumatriptan—DRD2—brain—nicotine dependence	0.000607	0.0267	CbGeAlD
Sumatriptan—Discomfort—Varenicline—nicotine dependence	0.000606	0.00295	CcSEcCtD
Sumatriptan—MAOA—Biological oxidations—CYP2A7—nicotine dependence	0.0006	0.00878	CbGpPWpGaD
Sumatriptan—Dry mouth—Varenicline—nicotine dependence	0.000599	0.00292	CcSEcCtD
Sumatriptan—MAOA—Neuronal System—CHRNB3—nicotine dependence	0.000594	0.0087	CbGpPWpGaD
Sumatriptan—Oedema—Varenicline—nicotine dependence	0.000587	0.00286	CcSEcCtD
Sumatriptan—Infection—Varenicline—nicotine dependence	0.000584	0.00284	CcSEcCtD
Sumatriptan—Shock—Varenicline—nicotine dependence	0.000578	0.00282	CcSEcCtD
Sumatriptan—Nervous system disorder—Varenicline—nicotine dependence	0.000576	0.00281	CcSEcCtD
Sumatriptan—Thrombocytopenia—Varenicline—nicotine dependence	0.000575	0.0028	CcSEcCtD
Sumatriptan—Tachycardia—Varenicline—nicotine dependence	0.000573	0.00279	CcSEcCtD
Sumatriptan—Skin disorder—Varenicline—nicotine dependence	0.000571	0.00278	CcSEcCtD
Sumatriptan—Hyperhidrosis—Varenicline—nicotine dependence	0.000568	0.00277	CcSEcCtD
Sumatriptan—MAOA—Neuronal System—CHRNA6—nicotine dependence	0.000563	0.00825	CbGpPWpGaD
Sumatriptan—Hypotension—Varenicline—nicotine dependence	0.000549	0.00267	CcSEcCtD
Sumatriptan—HTR1F—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000545	0.00797	CbGpPWpGaD
Sumatriptan—DRD2—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.000541	0.00792	CbGpPWpGaD
Sumatriptan—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.000535	0.00261	CcSEcCtD
Sumatriptan—ABCB1—cardiovascular system—nicotine dependence	0.000534	0.0235	CbGeAlD
Sumatriptan—ABCG2—brain—nicotine dependence	0.000532	0.0234	CbGeAlD
Sumatriptan—MAOA—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.000532	0.00778	CbGpPWpGaD
Sumatriptan—HTR1A—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.000529	0.00774	CbGpPWpGaD
Sumatriptan—Dyspnoea—Varenicline—nicotine dependence	0.000524	0.00255	CcSEcCtD
Sumatriptan—Somnolence—Varenicline—nicotine dependence	0.000522	0.00254	CcSEcCtD
Sumatriptan—Decreased appetite—Varenicline—nicotine dependence	0.000511	0.00249	CcSEcCtD
Sumatriptan—MAOA—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00051	0.00746	CbGpPWpGaD
Sumatriptan—Gastrointestinal disorder—Varenicline—nicotine dependence	0.000507	0.00247	CcSEcCtD
Sumatriptan—Fatigue—Varenicline—nicotine dependence	0.000507	0.00247	CcSEcCtD
Sumatriptan—HTR1F—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000506	0.0074	CbGpPWpGaD
Sumatriptan—Constipation—Varenicline—nicotine dependence	0.000502	0.00245	CcSEcCtD
Sumatriptan—Pain—Varenicline—nicotine dependence	0.000502	0.00245	CcSEcCtD
Sumatriptan—HTR1D—GPCR ligand binding—TAS2R16—nicotine dependence	0.0005	0.00732	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR ligand binding—TAS2R16—nicotine dependence	0.00049	0.00717	CbGpPWpGaD
Sumatriptan—Feeling abnormal—Varenicline—nicotine dependence	0.000484	0.00236	CcSEcCtD
Sumatriptan—Gastrointestinal pain—Varenicline—nicotine dependence	0.00048	0.00234	CcSEcCtD
Sumatriptan—MAOA—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.000474	0.00694	CbGpPWpGaD
Sumatriptan—Urticaria—Varenicline—nicotine dependence	0.000467	0.00227	CcSEcCtD
Sumatriptan—Abdominal pain—Varenicline—nicotine dependence	0.000464	0.00226	CcSEcCtD
Sumatriptan—Body temperature increased—Varenicline—nicotine dependence	0.000464	0.00226	CcSEcCtD
Sumatriptan—HTR1F—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000442	0.00647	CbGpPWpGaD
Sumatriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000433	0.00634	CbGpPWpGaD
Sumatriptan—Hypersensitivity—Varenicline—nicotine dependence	0.000433	0.00211	CcSEcCtD
Sumatriptan—HTR3A—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000428	0.00627	CbGpPWpGaD
Sumatriptan—Asthenia—Varenicline—nicotine dependence	0.000422	0.00205	CcSEcCtD
Sumatriptan—ABCB1—midbrain—nicotine dependence	0.000417	0.0183	CbGeAlD
Sumatriptan—Pruritus—Varenicline—nicotine dependence	0.000416	0.00203	CcSEcCtD
Sumatriptan—MAOA—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.000415	0.00607	CbGpPWpGaD
Sumatriptan—MAOA—Neuronal System—GABRA4—nicotine dependence	0.000407	0.00596	CbGpPWpGaD
Sumatriptan—Diarrhoea—Varenicline—nicotine dependence	0.000402	0.00196	CcSEcCtD
Sumatriptan—HTR1F—Signaling by GPCR—TAS2R16—nicotine dependence	0.000402	0.00588	CbGpPWpGaD
Sumatriptan—HTR1F—G alpha (i) signalling events—DRD2—nicotine dependence	0.000394	0.00577	CbGpPWpGaD
Sumatriptan—MAOA—Neuronal System—CHRNB4—nicotine dependence	0.000391	0.00572	CbGpPWpGaD
Sumatriptan—Dizziness—Varenicline—nicotine dependence	0.000388	0.00189	CcSEcCtD
Sumatriptan—MAOA—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.000386	0.00565	CbGpPWpGaD
Sumatriptan—MAOA—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.000377	0.00551	CbGpPWpGaD
Sumatriptan—Vomiting—Varenicline—nicotine dependence	0.000374	0.00182	CcSEcCtD
Sumatriptan—HTR1A—GPCR ligand binding—TAS2R16—nicotine dependence	0.000373	0.00546	CbGpPWpGaD
Sumatriptan—Rash—Varenicline—nicotine dependence	0.00037	0.0018	CcSEcCtD
Sumatriptan—Dermatitis—Varenicline—nicotine dependence	0.00037	0.0018	CcSEcCtD
Sumatriptan—Headache—Varenicline—nicotine dependence	0.000368	0.00179	CcSEcCtD
Sumatriptan—HTR1F—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000366	0.00535	CbGpPWpGaD
Sumatriptan—MAOA—Neuronal System—CHRNA5—nicotine dependence	0.000363	0.00531	CbGpPWpGaD
Sumatriptan—HTR1A—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.000353	0.00516	CbGpPWpGaD
Sumatriptan—Nausea—Varenicline—nicotine dependence	0.000349	0.0017	CcSEcCtD
Sumatriptan—HTR1D—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000348	0.0051	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR downstream signaling—FGD1—nicotine dependence	0.000347	0.00508	CbGpPWpGaD
Sumatriptan—HTR1B—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000341	0.00499	CbGpPWpGaD
Sumatriptan—MAOA—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00034	0.00498	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR ligand binding—OPRM1—nicotine dependence	0.00033	0.00483	CbGpPWpGaD
Sumatriptan—DRD2—GPCR ligand binding—TAS2R16—nicotine dependence	0.000328	0.0048	CbGpPWpGaD
Sumatriptan—HTR1D—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000323	0.00473	CbGpPWpGaD
Sumatriptan—HTR1A—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00032	0.00469	CbGpPWpGaD
Sumatriptan—HTR1B—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000317	0.00463	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—FGD1—nicotine dependence	0.000315	0.00461	CbGpPWpGaD
Sumatriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000313	0.00458	CbGpPWpGaD
Sumatriptan—MAOA—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.000309	0.00452	CbGpPWpGaD
Sumatriptan—MAOA—Neuronal System—CHRNA3—nicotine dependence	0.000296	0.00433	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000283	0.00414	CbGpPWpGaD
Sumatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000277	0.00405	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000277	0.00405	CbGpPWpGaD
Sumatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000271	0.00397	CbGpPWpGaD
Sumatriptan—ABCB1—brain—nicotine dependence	0.000262	0.0115	CbGeAlD
Sumatriptan—MAOA—Neuronal System—CHRNB2—nicotine dependence	0.000261	0.00381	CbGpPWpGaD
Sumatriptan—HTR1A—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00026	0.0038	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—TAS2R16—nicotine dependence	0.000257	0.00376	CbGpPWpGaD
Sumatriptan—DRD2—Circadian rythm related genes—CHRNB2—nicotine dependence	0.000253	0.0037	CbGpPWpGaD
Sumatriptan—HTR1D—G alpha (i) signalling events—DRD2—nicotine dependence	0.000252	0.00369	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—TAS2R16—nicotine dependence	0.000251	0.00368	CbGpPWpGaD
Sumatriptan—HTR1B—G alpha (i) signalling events—DRD2—nicotine dependence	0.000247	0.00361	CbGpPWpGaD
Sumatriptan—HTR1A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000241	0.00353	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR ligand binding—DRD2—nicotine dependence	0.000238	0.00349	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—TAS2R16—nicotine dependence	0.000237	0.00347	CbGpPWpGaD
Sumatriptan—MAOA—Neuronal System—CHRNA4—nicotine dependence	0.000237	0.00346	CbGpPWpGaD
Sumatriptan—SLCO1A2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000236	0.00346	CbGpPWpGaD
Sumatriptan—HTR1D—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000234	0.00342	CbGpPWpGaD
Sumatriptan—HTR1B—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000229	0.00335	CbGpPWpGaD
Sumatriptan—DRD2—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000228	0.00334	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—FGD1—nicotine dependence	0.000222	0.00325	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—FGD1—nicotine dependence	0.000217	0.00318	CbGpPWpGaD
Sumatriptan—DRD2—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000212	0.0031	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR ligand binding—OPRM1—nicotine dependence	0.000211	0.00309	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000211	0.00309	CbGpPWpGaD
Sumatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000207	0.00302	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR ligand binding—OPRM1—nicotine dependence	0.000207	0.00302	CbGpPWpGaD
Sumatriptan—SLCO1B1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000202	0.00296	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—FGD1—nicotine dependence	0.000202	0.00295	CbGpPWpGaD
Sumatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.0002	0.00293	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—FGD1—nicotine dependence	0.000197	0.00289	CbGpPWpGaD
Sumatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000196	0.00287	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—TAS2R16—nicotine dependence	0.000192	0.0028	CbGpPWpGaD
Sumatriptan—HTR1A—G alpha (i) signalling events—DRD2—nicotine dependence	0.000188	0.00275	CbGpPWpGaD
Sumatriptan—ABCG2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000187	0.00274	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR downstream signaling—OPRM1—nicotine dependence	0.000186	0.00273	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—FGD1—nicotine dependence	0.000186	0.00272	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000185	0.00271	CbGpPWpGaD
Sumatriptan—DRD2—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000181	0.00266	CbGpPWpGaD
Sumatriptan—HTR1A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000174	0.00255	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—OPRM1—nicotine dependence	0.000169	0.00248	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—TAS2R16—nicotine dependence	0.000168	0.00246	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—FGD1—nicotine dependence	0.000166	0.00242	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—AKR1B10—nicotine dependence	0.000164	0.00241	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR ligand binding—OPRM1—nicotine dependence	0.000157	0.0023	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR ligand binding—DRD2—nicotine dependence	0.000153	0.00223	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—TAS2R16—nicotine dependence	0.000152	0.00222	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—FGD1—nicotine dependence	0.00015	0.0022	CbGpPWpGaD
Sumatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000149	0.00219	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR ligand binding—DRD2—nicotine dependence	0.000149	0.00219	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—TAS2R16—nicotine dependence	0.000149	0.00217	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—FGD1—nicotine dependence	0.000145	0.00213	CbGpPWpGaD
Sumatriptan—DRD2—GPCR ligand binding—OPRM1—nicotine dependence	0.000138	0.00202	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR downstream signaling—DRD2—nicotine dependence	0.000135	0.00197	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—FGD1—nicotine dependence	0.000132	0.00193	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—DRD2—nicotine dependence	0.000122	0.00179	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—OPRM1—nicotine dependence	0.000119	0.00174	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—FGD1—nicotine dependence	0.000119	0.00174	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—OPRM1—nicotine dependence	0.000117	0.00171	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—FGD1—nicotine dependence	0.000117	0.00171	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—WASF2—nicotine dependence	0.000116	0.0017	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR ligand binding—DRD2—nicotine dependence	0.000114	0.00167	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—TAS2R16—nicotine dependence	0.000113	0.00166	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—WASF1—nicotine dependence	0.000111	0.00163	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—CYP2A7—nicotine dependence	0.000111	0.00162	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—OPRM1—nicotine dependence	0.000108	0.00158	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—OPRM1—nicotine dependence	0.000106	0.00155	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—AKR1B10—nicotine dependence	0.000105	0.00154	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—AKR1B10—nicotine dependence	0.000103	0.00151	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—CYP2A7—nicotine dependence	0.000103	0.0015	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000101	0.00148	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—OPRM1—nicotine dependence	0.0001	0.00146	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—TAS2R16—nicotine dependence	9.93e-05	0.00145	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—CYP2A7—nicotine dependence	9.47e-05	0.00139	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—OPRM1—nicotine dependence	8.89e-05	0.0013	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—FGD1—nicotine dependence	8.88e-05	0.0013	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—CYP2A7—nicotine dependence	8.77e-05	0.00128	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—DRD2—nicotine dependence	8.62e-05	0.00126	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—DRD2—nicotine dependence	8.44e-05	0.00124	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—OPRM1—nicotine dependence	8.07e-05	0.00118	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—AKR1B10—nicotine dependence	7.84e-05	0.00115	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—DRD2—nicotine dependence	7.83e-05	0.00115	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—OPRM1—nicotine dependence	7.81e-05	0.00114	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—FGD1—nicotine dependence	7.8e-05	0.00114	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—DRD2—nicotine dependence	7.66e-05	0.00112	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—WASF2—nicotine dependence	7.41e-05	0.00108	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—WASF2—nicotine dependence	7.25e-05	0.00106	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—DRD2—nicotine dependence	7.23e-05	0.00106	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—WASF1—nicotine dependence	7.1e-05	0.00104	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—OPRM1—nicotine dependence	7.09e-05	0.00104	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—WASF1—nicotine dependence	6.95e-05	0.00102	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—AKR1B10—nicotine dependence	6.89e-05	0.00101	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—DRD2—nicotine dependence	6.43e-05	0.000941	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—OPRM1—nicotine dependence	6.4e-05	0.000936	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—OPRM1—nicotine dependence	6.26e-05	0.000916	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—DRD2—nicotine dependence	5.84e-05	0.000854	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—WASF2—nicotine dependence	5.53e-05	0.000809	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—WASF1—nicotine dependence	5.3e-05	0.000775	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—WASF2—nicotine dependence	4.85e-05	0.00071	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—OPRM1—nicotine dependence	4.77e-05	0.000698	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CYP2A7—nicotine dependence	4.74e-05	0.000694	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—WASF1—nicotine dependence	4.65e-05	0.000681	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—DRD2—nicotine dependence	4.62e-05	0.000677	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—DRD2—nicotine dependence	4.53e-05	0.000663	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—OPRM1—nicotine dependence	4.19e-05	0.000613	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—DRD2—nicotine dependence	3.45e-05	0.000505	CbGpPWpGaD
